Words of wisdom. Re: Pathologic characteristics of cancers detected in the Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention

Affiliations

Comment

Paul F Schellhammer. Eur Urol. 2009 Feb.

. 2009 Feb;55(2):522-3.

doi: 10.1016/j.eururo.2008.11.015.

No abstract available

Comment on

Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention.
Lucia MS, Darke AK, Goodman PJ, La Rosa FG, Parnes HL, Ford LG, Coltman CA Jr, Thompson IM. Lucia MS, et al. Cancer Prev Res (Phila). 2008 Aug;1(3):167-73. doi: 10.1158/1940-6207.CAPR-08-0078. Epub 2008 May 18. Cancer Prev Res (Phila). 2008. PMID: 19138952 Free PMC article. Clinical Trial.
Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach.
Redman MW, Tangen CM, Goodman PJ, Lucia MS, Coltman CA Jr, Thompson IM. Redman MW, et al. Cancer Prev Res (Phila). 2008 Aug;1(3):174-81. doi: 10.1158/1940-6207.CAPR-08-0092. Epub 2008 May 18. Cancer Prev Res (Phila). 2008. PMID: 19138953 Free PMC article. Clinical Trial.